Nina King says that Ozempic's rise could shift beauty standards away from thinness as it becomes more accessible.

the active ingredient in Ozempic. The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes ...

But, Krumholz noted, the newer GLP-1 drugs, which are given as weekly injections instead of daily ones, have shown stronger benefits, especially for patients with obesity – and those aren’t yet ...